- ￥2457
- Biorbyt
- orb1945631
- 英国
- 2025年07月15日
- IHC
- Mouse
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
KBA.62 (Melanoma Associated Antigen) 抗体
- 抗体英文名：
KBA.62 (Melanoma Associated Antigen)
- 浓度：
详询
- 应用范围：
IHC
- 宿主：
Mouse
- 适应物种：
Human
- 保质期：
6-12个月
- 抗原来源：
详询
- 目录编号：
orb1945631
- 级别：
科研
- 库存：
99
- 供应商：
Biorbyt
- 标记物：
Unconjugated
- 克隆性：
MONOCLONAL
- 保存条件：
Store at 2-8°C. To ensure stability, immediately replace vial back in the refrigerator after each use
- 形态：
详询
- 亚型：
IgG1
- 免疫原：
详询
- 规格：
0.1 ml
KBA.62, also known as Melanoma Associated Antigen, is used to detect an antigen present in melanocytic tumours, such as melanomas, due to its proven sensitivity and specificity. The antibody can also be used to distinguish between junctional nevus and intradermal nevus cells, and fetal melanocytes versus normal adult melanocytes. Studies have shown KBA.62 to be highly useful in differentiating between metastatic amelanotic melanoma and a number of poorly differentiated carcinomas, large cell lymphomas, sarcomas, and spindle cell carcinomas.
产品名：KBA.62 (Melanoma Associated Antigen)
货号：orb1945631
产品中文名：KBA.62 (Melanoma Associated Antigen) 抗体
产品详情链接：https://www.biorbyt.com/kba62-melanoma-associated-an-orb1945631.html
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验protein)，E-选择素还结合CD62P配体CDl62(PSGL-1)，后者表达于淋巴细胞、中性粒细胞和单核细胞。皮肤淋巴细胞相关抗原(cutaneous lymphocyte associated antigen，CLA)归巢受体是慢性炎症皮肤部位表达的E-选择素的受体。CD62E主要介导白细胞(中性粒细胞、单核细胞和CD4+记忆性T细胞)在内皮细胞表面最初的滞留和滚动，以及随后迁移到炎症的组织。
A method to identify p62s UBA domain interacting proteins
. Using the rabbit reticulocyte lysatein vitro expression cloning system, we have successfully identified eleven proteins that interact with p62’s UBA domain, and the majority of the eleven proteins are associated with neurodegenerative disorders
Identification of Tumor-Associated Antigens as Diagnostic and Predictive Biomarkers in Cancer
be involved in malignant transformation. In this manner, several novel TAAs including HCC1, p62, p90, and others have been identified. In extension of these studies, we evaluate the sensitivity and specificity of different antigen-antibody systems as markers
技术资料暂无技术资料 索取技术资料
